Financing round-up: Remedial Health, Immunify.Life, Kamari Pharma, Great Bay Bio, Aignostics

Germany: Aignostics, a developer of digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, has closed an oversubscribed €14m (US$13.8m) Series A financing round led by Wellington Partners. Existing investors Boehringer Ingelheim Venture Fund (BIVF), VC Fonds Technologie managed by IBB Ventures and High-Tech Gründerfonds (HTGF) joined the round. CARMA Fund, initiated by…

You must be a HMI Subscriber to view this content.

Subscribe Now »